Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma
Clinical trial NCT01213472 · COMPLETED
Trial details
- NCT number
- NCT01213472
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-31
- Primary completion
- 2018-04-17
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.